Card image cap

Doris Matsui's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic for U.S. House (CA) - District 7

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 2
Date Title
12/07/2021 Matsui Introduces Bipartisan Legislation to Support Access to Evidence-Based Care for Rare Disease Patients
09/14/2020 Letter to the Hon. Alex M. Azar II, Secretary of the U.S. Dept. of Health and Human Services - Matsui, McKinley, DeGette, Gianforte, Welch, Johnson Lead Bipartisan Effort to Stand Up for Hospitals, Clinics Serving Low-Income Patients
03/03/2020 Johnson's Bipartisan Opioid Legislation Receives Hearing in House
01/23/2020 Letter to Alex Azar, Secretary of the Department of Health and Human Services - Lawmakers Call on Administration to Ban Flavored Vaping Products
03/28/2019 Letter to Chairwoman Rosa DeLauro and Ranking Member Tom Cole - Congressman Rose Leads Push to Increase Funding for Opioid Treatment, Prevention Efforts
01/30/2019 Matsui, Johnson Introduce Bipartisan Legislation to Reduce Teen Abuse of Over-the-Counter Cough Medicines
07/26/2018 Sens. Coons, Gardner & Reps. Lance, Matsui Introduce Legislation to Address the Opioid Crisis Through the Prevention of Drug Diversion
07/11/2018 Matsui Opening Remarks at 340B Drug Pricing Program Hearing
06/22/2018 Matsui's Telehealth Legislation to Increase Access to Behavioral Health Treatment Passes House as Part of Bipartisan Opioids Package
06/20/2018 Providing for Consideration of H.R. Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act; Providing for Consideration of H.R. Individuals in Medicaid Deserve Care That is Appropriate and Responsible in its Execution Act; and Providing for Consideration of H.R. Overdose Prevention and Patient Safety Act
06/12/2018 Matsui Introduces Legislation in Support of 340B Program
05/17/2018 Energy & Commerce Committee Unanimously Passes Matsui's Telehealth Legislation to Increase Access to Behavioral Health Treatment
05/08/2018 Hearing of the Health Subcommittee - Opening Statement of Rep. Matsui, Hearing on Improving the Coordination and Quality of Substance Use Disorder Treatment
04/25/2018 Matsui Opening Remarks at Health Subcommittee Markup of Opioid Legislation
04/24/2018 Matsui Introduces Two Bills that Leverage Telehealth to Increase Access to Behavioral Health Treatment
02/28/2018 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Matsui, Hearing on Combating the Opioids Crisis: Helping Communities Balance Enforcement and Patient Safety
05/16/2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding
09/09/2016 Congresswoman Matsui Demands Answers on Affordability of EpiPen for Families
07/06/2016 Congresswoman Matsui Calls for More Funding to Address Opioid and Heroin Epidemic
05/13/2016 Comprehensive Addiction and Recovery Act of 2016
05/11/2016 Congresswoman Matsui Calls for Comprehensive Approach to Substance Abuse Crisis
05/04/2016 Letter to the Hon. Paul Ryan, Speaker of the House - Consider Emergency Funding To Address Opioid And Heroin Epidemic
04/28/2016 Committee Advances 12 Bills to Address Opioid Abuse Epidemic
04/28/2016 Johnson-Matsui DXM Abuse Prevention Act Passes as Part of Energy & Commerce Committee Action on Opioid and Substance Abuse Crisis
04/20/2016 Energy & Commerce Health Subcommittee Advances Matsui-Johnson DXM Abuse Prevention Act
Page 1 of 2
arrow_upward